Analysts up AmSurg's price target to $60.67

Twelve analysts have raised their rating of AmSurg stock to "buy," according to a Sleek Money report.

The average 12-month price target on the company stock within the last year is $60.67, according to the report. The company has a one-year high of $62.83 and a one-year low of $40.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast